Also known as: Diassess
Next generation infectious disease test kits
Company went public
Event Year: 2014
Company went public
Event Year: 2014
Lucira Health aimed to transform infectious disease management through innovative diagnostic solutions. The company focused on developing tools that would empower individuals to proactively understand and manage their health. Their core product was designed as an affordable, single-use diagnostic device capable of turning any smartphone into a portable, real-time health monitoring system. This technology enabled rapid, accessible, and multiplexed analysis of bodily fluids, providing users with health insights from anywhere in the world. The vision was to decentralize and democratize access to critical health information.
Lucira Health aimed to transform infectious disease management through innovative diagnostic solutions. The company focused on developing tools that would empower individuals to proactively understand and manage their health. Their core product was designed as an affordable, single-use diagnostic device capable of turning any smartphone into a portable, real-time health monitoring system. This technology enabled rapid, accessible, and multiplexed analysis of bodily fluids, providing users with health insights from anywhere in the world. The vision was to decentralize and democratize access to critical health information.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2015
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2015
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 43
Hiring: No
Team size: 43
Hiring: No